Imricor Medical Systems, Inc. (ASX: IMR) | ARBN 633 106 019 400 Gateway Blvd. | Burnsville, Minnesota 55337 USA | +1 952.818.8400 | imricor.com IMRICOR AND PHILIPS LAUNCH COMMERCIAL IMR LAB SOLUTION Global collaboration advances MR-guided cardiac interventions toward...
Imricor and Philips Launch Commercial iMR Lab Solution
Filed with ASX · · 3 pages · English
Summary by 6ix AI
Imricor Medical Systems, Inc. has announced the commercial launch of a new Interventional MR lab solution in collaboration with Philips, aimed at enhancing MR-guided cardiac interventions. The integrated solution combines Philips’ MRI platform with Imricor’s MR-compatible systems and tools, designed for cardiac procedures. The solution is immediately available in CE-marked markets and selected configurations are also available in the United States.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Imricor Medical Systems, Inc. on 6ix
Story so far
Earlier from Imricor Medical Systems
- Imricor U.S. Commercial Momentum Accelerates
- 1H 2026 Investor Presentation
- 2026 Q2 Form 10-Q
- Q2 CY2026 Quarterly Activities Report & Form 10-Q Submission
- Philips Declares Compatibility with Imricor
Later from Imricor Medical Systems
- Release from Voluntary Escrow
- FDA Accepts Imricor PMA Manufacturing Module
- S&P DJI Announces September 2026 Quarterly Rebalance
- Application for quotation of securities - IMR
- Cleansing Notice
Follow Imricor Medical Systems into a list and get an email when it puts out news.
Follow Imricor Medical Systems